⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$2.4T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $749.60B | $833.49 | 2.56% |
| ABT | Abbott Laboratories | $230.73B | $132.57 | 0.56% |
| TMO | Thermo Fisher Scientific Inc. | $198.17B | $524.80 | 1.85% |
| DHR | Danaher Corporation | $144.97B | $202.46 | 0.99% |
| BSX | Boston Scientific Corporation | $141.37B | $95.41 | 1.92% |
| MDT | Medtronic plc | $122.43B | $95.45 | 1.09% |
| VRTX | Vertex Pharmaceuticals Incorporated | $104.55B | $407.79 | 1.70% |
| ZTS | Zoetis Inc. | $62.54B | $141.11 | 1.59% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $60.36B | $460.46 | 0.77% |
| REGN | Regeneron Pharmaceuticals, Inc. | $58.82B | $564.63 | 0.92% |
| IDXX | IDEXX Laboratories, Inc. | $49.29B | $616.15 | 2.00% |
| EW | Edwards Lifesciences Corporation | $43.41B | $73.94 | 1.66% |
| GEHC | GE HealthCare Technologies Inc. | $32.42B | $71.01 | 4.33% |
| DXCM | DexCom, Inc. | $25.54B | $65.12 | 4.35% |
| NTRA | Natera, Inc. | $23.23B | $169.27 | 2.19% |
| LH | Laboratory Corporation of America Holdings | $23.09B | $277.88 | 0.04% |
| DGX | Quest Diagnostics Incorporated | $20.58B | $184.07 | 1.45% |
| TEM | Tempus AI, Inc. | $16.26B | $96.39 | 2.91% |
| HOLX | Hologic, Inc. | $15.07B | $67.76 | 1.25% |
| ILMN | Illumina, Inc. | $14.43B | $93.86 | 2.69% |
| MEDP | Medpace Holdings, Inc. | $14.08B | $501.22 | 3.37% |
| SOLV | Solventum Corporation | $12.23B | $70.52 | 1.78% |
| IONS | Ionis Pharmaceuticals, Inc. | $11.15B | $69.97 | 0.43% |
| EXAS | Exact Sciences Corporation | $11.04B | $58.34 | 1.88% |
| BBIO | BridgeBio Pharma, Inc. | $10.61B | $55.49 | 1.28% |
| EXEL | Exelixis, Inc. | $10.27B | $38.15 | 1.09% |
| TECH | Bio-Techne Corporation | $9.24B | $58.66 | 2.07% |
| AVTR | Avantor, Inc. | $9.14B | $13.40 | 1.03% |
| DVA | DaVita Inc. | $8.87B | $123.99 | 1.89% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| RGEN | Repligen Corporation | $8.17B | $145.24 | 2.40% |
| BIO | Bio-Rad Laboratories, Inc. | $8.06B | $297.72 | 0.97% |
| GH | Guardant Health, Inc. | $8.01B | $64.22 | 1.59% |
| HSIC | Henry Schein, Inc. | $7.66B | $63.17 | 2.17% |
| RNA | Avidity Biosciences, Inc. | $6.40B | $49.77 | 1.97% |
| CHE | Chemed Corporation | $6.27B | $430.02 | 0.32% |
| IRTC | iRhythm Technologies, Inc. | $5.66B | $176.20 | 0.20% |
| RDNT | RadNet, Inc. | $5.43B | $70.60 | 3.08% |
| BRKR | Bruker Corporation | $5.35B | $35.28 | 1.81% |
| PTCT | PTC Therapeutics, Inc. | $5.26B | $66.23 | 0.33% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $4.90B | $35.41 | 1.80% |
| SHC | Sotera Health Company | $4.36B | $15.35 | 2.73% |
| KYMR | Kymera Therapeutics, Inc. | $4.09B | $57.21 | 0.33% |
| SRRK | Scholar Rock Holding Corporation | $3.79B | $39.46 | 3.73% |
| LNTH | Lantheus Holdings, Inc. | $3.64B | $53.54 | 2.20% |
| ADMA | ADMA Biologics, Inc. | $3.47B | $14.54 | 1.36% |
| AMED | Amedisys, Inc. | $3.32B | $100.99 | 0.01% |
| CGON | CG Oncology, Inc. Common stock | $3.30B | $43.25 | 2.72% |
| APLS | Apellis Pharmaceuticals, Inc. | $3.17B | $25.12 | 2.37% |
| NVST | Envista Holdings Corp | $3.17B | $19.06 | 5.60% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.03B | $31.45 | 0.66% |
| CON | Concentra Group Holdings Parent, Inc. | $2.60B | $20.31 | 2.68% |
| BLTE | Belite Bio, Inc | $2.58B | $79.28 | 0.99% |
| FOLD | Amicus Therapeutics, Inc. | $2.56B | $8.30 | 0.36% |
| GRAL | GRAIL, Inc. | $2.38B | $66.13 | 7.03% |
| HAE | Haemonetics Corporation | $2.35B | $48.85 | 2.59% |
| ADPT | Adaptive Biotechnologies Corporation | $2.31B | $15.17 | 3.07% |
| IDYA | IDEAYA Biosciences, Inc. | $2.30B | $26.24 | 2.05% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.29B | $5.32 | 9.98% |
| DNLI | Denali Therapeutics Inc. | $2.25B | $15.37 | 4.95% |
| IBRX | ImmunityBio, Inc. | $2.23B | $2.36 | 3.28% |
| ARDT | Ardent Health Partners, LLC | $2.01B | $14.05 | 2.02% |
| CERT | Certara, Inc. | $1.90B | $11.86 | 8.35% |
| TWST | Twist Bioscience Corporation | $1.88B | $31.19 | 2.20% |
| QDEL | QuidelOrtho Corporation | $1.79B | $26.37 | 6.02% |
| PGNY | Progyny, Inc. | $1.73B | $20.10 | 2.28% |
| RCUS | Arcus Biosciences, Inc. | $1.55B | $14.60 | 3.69% |
| ASTH | Astrana Health, Inc. | $1.45B | $29.11 | 4.31% |
| TXG | 10x Genomics, Inc. | $1.43B | $11.47 | 2.05% |
| TDOC | Teladoc Health, Inc. | $1.41B | $8.00 | 9.60% |
| MD | Pediatrix Medical Group, Inc. | $1.38B | $15.80 | 2.59% |
| AZTA | Azenta, Inc. | $1.37B | $29.81 | 6.05% |
| NVAX | Novavax, Inc. | $1.35B | $8.33 | 3.03% |
| NEOG | Neogen Corporation | $1.31B | $6.04 | 10.91% |
| NUVB | Nuvation Bio Inc. | $1.28B | $3.74 | 0.27% |
| IMNM | Immunome, Inc. | $1.21B | $13.92 | 2.59% |
| OPK | OPKO Health, Inc. | $1.20B | $1.51 | 3.21% |
| DVAX | Dynavax Technologies Corporation | $1.17B | $9.96 | 3.77% |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $1.13B | $22.00 | 6.34% |
| PRAX | Praxis Precision Medicines, Inc. | $1.12B | $53.26 | 2.74% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $970.11M | $17.78 | 2.63% |
| BBNX | Beta Bionics, Inc. | $914.18M | $21.03 | 5.40% |
| PROK | ProKidney Corp. | $902.97M | $3.02 | 8.48% |
| FTRE | Fortrea Holdings Inc. | $878.49M | $9.68 | 10.00% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $866.88M | $3.19 | 3.33% |
| KURA | Kura Oncology, Inc. | $854.95M | $9.85 | 3.90% |
| GERN | Geron Corporation | $835.80M | $1.31 | 5.76% |
| TNGX | Tango Therapeutics, Inc. | $794.40M | $7.14 | 2.46% |
| ABUS | Arbutus Biopharma Corporation | $787.88M | $4.11 | 3.75% |
| CDNA | CareDx, Inc | $765.94M | $14.39 | 2.31% |
| NRIX | Nurix Therapeutics, Inc. | $750.34M | $9.76 | 10.13% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $749.39M | $13.52 | 11.29% |
| GYRE | Gyre Therapeutics, Inc. | $722.45M | $7.96 | 11.33% |
| PSNL | Personalis, Inc. | $720.06M | $8.12 | 5.69% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| MYGN | Myriad Genetics, Inc. | $697.83M | $7.50 | 3.10% |
| FLGT | Fulgent Genetics, Inc. | $689.01M | $22.51 | 0.79% |
| KROS | Keros Therapeutics, Inc. | $637.66M | $15.70 | 2.61% |
| SIGA | SIGA Technologies, Inc. | $588.60M | $8.22 | 2.66% |
| BFLY | Butterfly Network, Inc. | $574.40M | $2.28 | 11.28% |